Tech transfer remains one of the slowest, most frustrating bottlenecks in life sciences manufacturing, often stretching across half a decade or more. In a recent Qualitalks podcast episode, Qualistery Managing Director Yan Kugel spoke with Emerson VP of Marketing and Experience Nikki Bishop about why these projects stall and what actually helps close the gaps.
AI is changing drug discovery faster than most people expected. Commercial manufacturing is next. The organizations best positioned for that shift are the ones preparing now, not because they’re behind, but because the window to prepare thoughtfully is exactly when...
In Part 1, we explored why digital strategies that sit above operations break down in regulated life sciences manufacturing. When analytics are disconnected from validated execution, insight loses the context required to support quality, compliance, and release...
The common digital strategy playbook is: unify the data, layer on AI, and drive enterprise-level insight. The strategy sounds compelling in its simplicity. And for some industries and some use cases, it can work. But in regulated life sciences manufacturing, there is...
Emerson’s Nikki Bishop and Franz Valmonte join podcast host Jim Cahill to discuss innovations in DeltaV Edge 2.0 to help pharmaceutical and biopharmaceutical manufacturers reduce time to market and release times for the medicines and therapeutics they deliver to the world.
Our Global Community
Emerson Exchange 365
This blog features expert perspectives from Emerson's automation professionals on industry trends, technologies, and best practices. The information shared here is intended to inform and educate our global community of users and partners.